Results for tag: "Wilson Disease Drug"

Wilson Disease is a rare genetic disorder that affects the body's ability to metabolize copper. It is characterized by the accumulation of copper in the liver, brain, and other organs. Treatment for Wilson Disease typically involves the use of drugs to reduce the amount of copper in the body. These drugs are classified as Central Nervous System (CNS) drugs, and are used to treat a variety of neurological disorders. The Wilson Disease Drug market is a subset of the CNS drug market, and includes drugs specifically designed to treat Wilson Disease. These drugs are typically prescribed by neurologists and other specialists, and are used to reduce the amount of copper in the body. Commonly prescribed drugs include penicillamine, trientine, and zinc acetate. Companies in the Wilson Disease Drug market include Pfizer, Novartis, and Sanofi. These companies produce and market drugs specifically designed to treat Wilson Disease. Other companies, such as Merck and GlaxoSmithKline, also produce CNS drugs that may be used to treat Wilson Disease. Show Less Read more